Iron deficiency Iron-deficient erythropoiesis (IDE). Untreated iron deficiency can lead to iron deficiency anemia, a common type of anemia. Anemia is a condition characterized by inadequate red blood cells (erythrocytes) or hemoglobin. Iron deficiency anemia occurs when the body lacks sufficient amounts of iron, resulting in reduced production of the protein hemoglobin. Hemoglobin binds to oxygen, thus enabling red blood cells to supply oxygenated blood throughout the body. Children, pre-menopausal women (women of child-bearing age) and people with poor diet are most susceptible to the disease. Most cases of iron deficiency anemia are mild, but if not treated can cause problems like
Genetically engineered blood protein and a substance of choice, such as a small-molecule therapeutic agent or an antibody. The modifications leave the cells and their surfaces otherwise intact. One application is to engineer red blood cells into drug-delivery vehicles. Mature red cells carry no genetic material, potentially presenting fewer safety risks than other gene and cell therapies. Human red blood cells circulate for as long as four months, meaning they could potentially form the basis of long-term therapies. The cells move throughout body via the bloodstream and are unnoticed by the immune system. Genetically engineered blood Genetically engineered blood is blood that has